Back to Search
Start Over
Efficacy and safety of transurethral split of prostate for benign prostatic hyperplasia: a meta-analysis
- Source :
- BMC Urology, Vol 20, Iss 1, Pp 1-11 (2020)
- Publication Year :
- 2020
- Publisher :
- BMC, 2020.
-
Abstract
- Abstract Background Transurethral resection of the prostate (TURP) is the first choice for the treatment of benign prostatic hyperplasia. However, Transurethral split of prostate (TUSP) also seems to have clear clinical efficacy and clinical promotion value. To better clarify the potential and limitations of this treatment of prostate hyperplasia. This study objectively evaluated the clinical efficacy and safety of TUSP. Methods The Pubmed, Cochrane Library, Embase, China National Knowledge Infrastructure (CNKI), Database for Chinese Technical Periodicals (VIP), Wanfang (Wanfang data), and SinoMed databases were searched for relevant studies. We then used Revman Manager 5.3 to perform a meta-analysis of all randomized controlled trials that evaluated the efficacy and safety of TUSP versus the classic surgical procedures commonly used in the clinic. Results A total of 7 studies involving 592 patients were included. The combined data showed that TUSP can shorten the operation time [MD: -33.68; 95% CI: − 38.45 to − 28.91; P
Details
- Language :
- English
- ISSN :
- 14712490
- Volume :
- 20
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- BMC Urology
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.67f8c1012fe04910b99835fd556e6854
- Document Type :
- article
- Full Text :
- https://doi.org/10.1186/s12894-020-00704-4